ROME Therapeutics

ROME Therapeutics

生物技术研究

Boston,Massachusetts 9,394 位关注者

Harnessing the power of the repeatome to develop a new class of therapies for cancer and autoimmune diseases.

关于我们

ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome – vast stretches of uncharted genetic material that have long been dismissed as “junk DNA.” With several drug targets identified and multiple discovery programs underway, ROME is moving rapidly to leverage this new frontier in biology. To lead this exploration, ROME has assembled a team of world-class leaders across fields including oncology, immunology, virology and machine learning. ROME was launched in April 2020 and was incubated at GV, in collaboration with ARCH Venture Partners and Partners Innovation Fund. ROME is based in Cambridge, Mass. For more information, please visit www.rometx.com.

网站
https://rometx.com
所属行业
生物技术研究
规模
11-50 人
总部
Boston,Massachusetts
类型
私人持股
创立
2020

地点

  • 主要

    201 Brookline Ave

    US,Massachusetts,Boston,02215

    获取路线

ROME Therapeutics员工

动态

相似主页

查看职位

融资

ROME Therapeutics 共 3 轮

上一轮

B 轮

US$72,000,000.00

Crunchbase 上查看更多信息